News Conference News ESC Congress 2011: Drugs, Devices Work Together Caitlin E. Cox September 06, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011
News Conference News RESET: Largest Study to Date of Xience, Cypher Shows Noninferiority August 31, 2011
News Daily News TRIAS HR Published: Genous Stent Doubles Target Lesion Failure Leah Lawrence August 23, 2011
News Daily News No Apparent Advantage for Everolimus vs. Paclitaxel Stents in Diabetic Patients L.A. McKeown August 19, 2011
News Industry News Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's GenousTM Stent in Patients at High Risk for Restenosis August 16, 2011
News Daily News Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease Jason Kahn August 08, 2011
News Daily News SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year Caitlin E. Cox August 05, 2011
News Daily News ESSENCE-DIABETES Published: Xience, Cypher Equally Equipped to Treat Diabetics Caitlin E. Cox August 03, 2011
News Daily News Meta-analysis Finds Equivalence Between First-, Second-Generation DES L.A. McKeown August 02, 2011
News Industry News Medtronic Resolute® Drug-Eluting Stent Shows Superiority to Taxus® DES in Study of Patients with Coronary Artery Disease July 26, 2011
News Daily News ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute Jason Kahn July 21, 2011
News Industry News OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery July 18, 2011
News Daily News HORIZONS-AMI: Bivalirudin Reduces Cardiac Death in Diabetics Jason Kahn July 18, 2011
News Daily News DES Show Advantage over BMS for Heart Transplant Complication L.A. McKeown July 01, 2011
News Daily News HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years Jason Kahn June 13, 2011
News Daily News RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES L.A. McKeown June 10, 2011
News Daily News Complete Revascularization Irrelevant for Most Multivessel Disease Caitlin E. Cox June 03, 2011
News Industry News Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels May 24, 2011